Abstract
<p>Inhibition of mHsp70 results in decreased motility of patient-derived brain tumor cells. <b>A,</b> The process of isolating the primary human GBM cell line from postoperative material, obtaining confocal images, shooting on a live-cell imaging platform with the addition of inhibitors, and subsequent training and implementation of an AI model for tracking highly invasive cells. <b>B</b> and <b>C,</b> Representative confocal microscopy images of the patient-derived tumor cell lines stained for mHsp70 (green), SOX2 (magenta), and nestin (magenta). Nuclei were stained by DAPI (blue). Scale bars, 100 μm. <b>D,</b> CD133 expression in patient-derived tumor cells stained by PE-anti-CD133 antibody (as measured by flow cytometry). <b>E,</b> Comparison of mean speed and track straightness on various matrices (PL, MG, and FN) of patient-derived high-speed brain tumor cells treated with 1-μmol/L PES or 50-nmol/L JG98 (<i>n</i><sub>tracks</sub> ≥ 294). Nontreated cells were used as a control. Data are presented as median ± 95% CI. Significant differences identified by the Wilcoxon test are shown as *, <i>P</i> < 0.05; **, <i>P</i> < 0.01; ***, <i>P</i> < 0.001; ****, <i>P</i> < 0.0001; ns, not significant.</p>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.